Exane Derivatives’s Tilray TLRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-307
Closed -$23.9K 931
2022
Q1
$23.9K Buy
+307
New +$19.2K 0.01% 647
2021
Q4
Sell
-307
Closed -$34.7K 980
2021
Q3
$34.7K Hold
307
0.01% 654
2021
Q2
$50.2K Buy
307
+228
+289% +$40K 0.01% 649
2021
Q1
$18.1K Sell
79
-18
-19% -$4.22K 0.01% 571
2020
Q4
$7.99K Buy
97
+63
+185% +$4.59K ﹤0.01% 536
2020
Q3
$1.64K Sell
34
-1,273
-97% -$85K ﹤0.01% 581
2020
Q2
$93.1K Buy
1,307
+191
+17% +$15.4K 0.02% 303
2020
Q1
$76.9K Sell
1,116
-250
-18% -$34.9K 0.02% 312
2019
Q4
$292K Buy
1,366
+16
+1% +$3.31K 0.05% 210
2019
Q3
$334K Sell
1,350
-322
-19% -$117K 0.06% 192
2019
Q2
$780K Buy
1,672
+1,544
+1,206% +$738K 0.14% 121
2019
Q1
$83.9K Sell
128
-839
-87% -$640K 0.02% 314
2018
Q4
$683K Buy
967
+917
+1,834% +$1.01M 0.12% 148
2018
Q3
$69.5K Buy
+50
New +$32.1K 0.01% 354

Other funds holding TLRY

Exane Derivatives's TLRY Position: Q2 2022 in Review

Exane Derivatives sold out of Tilray (TLRY) in Q2 2022, closing a stake of 307 shares — an estimated $23.9K sold.

Exane Derivatives first reported a position in TLRY in Q3 2018 and held it in 14 quarters. The position peaked at $780K in Q2 2019. 354 funds tracked by Wall St. Rank hold TLRY as of Q2 2022.

  • Exane Derivatives reported no remaining Tilray position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 307 Tilray shares in Q2 2022, an estimated $23.9K.
  • Exane Derivatives first reported a position in Tilray in Q3 2018 and held it in 14 quarters.
  • Exane Derivatives's Tilray position peaked at $780K in Q2 2019.
  • 354 funds tracked by Wall St. Rank held Tilray as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.